 | The 131st Annual Meeting (November 15-19, 2003) of APHA |
|
| The 131st Annual Meeting (November 15-19, 2003) of APHA |
Lisa M. Hund, MPH, CHES, Health, Social, and Economics Research, RTI International, 3040 Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC 27709, (919)485-2637, lisahund@rti.org, Matthew Farrelly, PhD, Research Triangle Institute, 3040 Cornwallis Drive, Research Triangle Park, NC 27709, Kevin Davis, MA, Tobacco Use Research Program, Research Triangle Institute, 3040 Cornwallis Rd, Durham, NC 27709, and Lyndon Haviland, PhD, Chief Operating Officer, American Legacy Foundation, 1001 G Street, Suite 800, Washington, DC 20001.
Tobacco companies have recently introduced new products that claim to have reduced toxins and carcinogens and hence may be less harmful to smokers. Much controversy has surrounded the introduction of these products for a variety of reasons including how to scientifically quantify and demonstrate reduced exposure to toxins. While the debate continues, these products are being marketed to smokers. However, very little information is known about smokers' awareness, risk perceptions, and use of these products. The American Legacy Foundation sponsored a nationally representative survey of adults in 2002 that addresses these questions. The survey sample consists of over 3,000 adults and 700 smokers. We will present data on awareness, risk perceptions, and use of potentially reduced exposure products as well as differences by gender and race/ethnicity and intentions to quit.
Learning Objectives:
Keywords: Tobacco, Public Health Careers
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: American Legacy Foundation
I have a significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.
Relationship: RTI is Legacy's Research and Evaluation Coordinating Center